Arcadia Biosciences, Inc.
RKDA
$1.12
$0.076.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.34M | 856.00K | -4.46M | 2.60M | -4.06M |
| Total Depreciation and Amortization | 2.00K | 7.00K | 28.00K | 117.00K | 171.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.00K | -1.95M | 3.06M | -3.60M | 2.16M |
| Change in Net Operating Assets | 504.00K | 830.00K | -659.00K | -701.00K | -471.00K |
| Cash from Operations | -861.00K | -257.00K | -2.03M | -1.59M | -2.21M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -8.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 250.00K | 500.00K | 2.52M |
| Cash from Investing | 0.00 | 0.00 | 250.00K | 500.00K | 2.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.00K | 0.00 | 5.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 1.00K | 0.00 | 5.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -861.00K | -256.00K | -1.78M | -1.08M | 306.00K |